To validate the link between IL-6 and EMT in NSCLC cells, NCI-H292 and NCI-H460 cells were directly treated with recombinant human IL-6, and EMT markers were evaluated by Western blotting. This evidence concerns the gene IL6 and non-small cell lung carcinoma.